These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 30852368)

  • 21. Identification and structure-activity relationship of purine derivatives as novel MTH1 inhibitors.
    Kumar A; Kawamura T; Kawatani M; Osada H; Zhang KYJ
    Chem Biol Drug Des; 2017 Jun; 89(6):862-869. PubMed ID: 27863017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational specificity of mice defective in the MTH1 and/or the MSH2 genes.
    Egashira A; Yamauchi K; Yoshiyama K; Kawate H; Katsuki M; Sekiguchi M; Sugimachi K; Maki H; Tsuzuki T
    DNA Repair (Amst); 2002 Nov; 1(11):881-93. PubMed ID: 12531017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways.
    Patel A; Burton DG; Halvorsen K; Balkan W; Reiner T; Perez-Stable C; Cohen A; Munoz A; Giribaldi MG; Singh S; Robbins DJ; Nguyen DM; Rai P
    Oncogene; 2015 May; 34(20):2586-96. PubMed ID: 25023700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MTH1 protects platelet mitochondria from oxidative damage and regulates platelet function and thrombosis.
    Ding Y; Gui X; Chu X; Sun Y; Zhang S; Tong H; Ju W; Li Y; Sun Z; Xu M; Li Z; Andrews RK; Gardiner EE; Zeng L; Xu K; Qiao J
    Nat Commun; 2023 Aug; 14(1):4829. PubMed ID: 37563135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Augment of Oxidative Damage with Enhanced Photodynamic Process and MTH1 Inhibition for Tumor Therapy.
    Hu JJ; Chen Y; Li ZH; Peng SY; Sun Y; Zhang XZ
    Nano Lett; 2019 Aug; 19(8):5568-5576. PubMed ID: 31262183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of a new class of MTH1 inhibitor by X-ray crystallographic screening.
    Yokoyama T; Kitakami R; Mizuguchi M
    Eur J Med Chem; 2019 Apr; 167():153-160. PubMed ID: 30771603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MTH1 as a nucleotide pool sanitizing enzyme: Friend or foe?
    Nakabeppu Y; Ohta E; Abolhassani N
    Free Radic Biol Med; 2017 Jun; 107():151-158. PubMed ID: 27833032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity of Escherichia coli (MutT) and human (MTH1) 8-oxo-dGTPases to in vitro inhibition by the carcinogenic metals, nickel(II), copper(II), cobalt(II) and cadmium(II).
    Porter DW; Yakushiji H; Nakabeppu Y; Sekiguchi M; Fivash MJ; Kasprzak KS
    Carcinogenesis; 1997 Sep; 18(9):1785-91. PubMed ID: 9328176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MTH1, an oxidized purine nucleoside triphosphatase, prevents the cytotoxicity and neurotoxicity of oxidized purine nucleotides.
    Nakabeppu Y; Kajitani K; Sakamoto K; Yamaguchi H; Tsuchimoto D
    DNA Repair (Amst); 2006 Jul; 5(7):761-72. PubMed ID: 16621731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sanitation enzymes: Exquisite surveillance of the noncanonical nucleotide pool to safeguard the genetic blueprint.
    Broderick K; Moutaoufik MT; Aly KA; Babu M
    Semin Cancer Biol; 2023 Sep; 94():11-20. PubMed ID: 37211293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the nucleic acid oxidative damage repair enzyme MTH1: a promising therapeutic option.
    Ding Y; Liu Q
    Front Cell Dev Biol; 2024; 12():1334417. PubMed ID: 38357002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidized nucleotide insertion by pol β confounds ligation during base excision repair.
    Çağlayan M; Horton JK; Dai DP; Stefanick DF; Wilson SH
    Nat Commun; 2017 Jan; 8():14045. PubMed ID: 28067232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal Structures and Inhibitor Interactions of Mouse and Dog MTH1 Reveal Species-Specific Differences in Affinity.
    Narwal M; Jemth AS; Gustafsson R; Almlöf I; Warpman Berglund U; Helleday T; Stenmark P
    Biochemistry; 2018 Feb; 57(5):593-603. PubMed ID: 29281266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MTH1 favors mesothelioma progression and mediates paracrine rescue of bystander endothelium from oxidative damage.
    Magkouta SF; Pappas AG; Vaitsi PC; Agioutantis PC; Pateras IS; Moschos CA; Iliopoulou MP; Kosti CN; Loutrari HV; Gorgoulis VG; Kalomenidis IT
    JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32554927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancing Repair of Oxidative DNA Damage with Small-Molecule Activators of MTH1.
    Lee Y; Onishi Y; McPherson L; Kietrys AM; Hebenbrock M; Jun YW; Das I; Adimoolam S; Ji D; Mohsen MG; Ford JM; Kool ET
    ACS Chem Biol; 2022 Aug; 17(8):2074-2087. PubMed ID: 35830623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous elimination of oxidized nucleotides is necessary to prevent rapid onset of cellular senescence.
    Rai P; Onder TT; Young JJ; McFaline JL; Pang B; Dedon PC; Weinberg RA
    Proc Natl Acad Sci U S A; 2009 Jan; 106(1):169-74. PubMed ID: 19118192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence.
    Rai P; Young JJ; Burton DG; Giribaldi MG; Onder TT; Weinberg RA
    Oncogene; 2011 Mar; 30(12):1489-96. PubMed ID: 21076467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The presumed MTH1-inhibitor TH588 sensitizes colorectal carcinoma cells to ionizing radiation in hypoxia.
    Pompsch M; Vogel J; Classen F; Kranz P; Iliakis G; Riffkin H; Brockmeier U; Metzen E
    BMC Cancer; 2018 Nov; 18(1):1190. PubMed ID: 30497423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of As3mt and Mth1 in the genotoxic and carcinogenic effects induced by long-term exposures to arsenic in MEF cells.
    Barguilla I; Peremartí J; Bach J; Marcos R; Hernández A
    Toxicol Appl Pharmacol; 2020 Dec; 409():115303. PubMed ID: 33141059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model.
    Moukengue B; Brown HK; Charrier C; Battaglia S; Baud'huin M; Quillard T; Pham TM; Pateras IS; Gorgoulis VG; Helleday T; Heymann D; Berglund UW; Ory B; Lamoureux F
    EBioMedicine; 2020 Mar; 53():102704. PubMed ID: 32151797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.